Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Ahmet Sarıcı; Mehmet Ali Erkurt; Ömer Faruk Bahçecíoğlu; Lokman Hekim Tanrıverdi; Ilhami Berber; Emın Kaya; Soykan Biçim; Selim Gök; Mustafa Özgül; İrfan Kuku

doi:10.5455/annalsmedres.2021.03.206

Back

Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Article 2021 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Ahmet Sarıcı, Mehmet Ali Erkurt, İrfan Kuku, Emın Kaya, Ilhami Berber, Soykan Biçim, Emine Hidayet, Ahmet Kaya, Ömer Faruk Bahçecíoğlu, Lokman Hekim Tanrıverdi, Sıdıka Gülkan Özkan

Article2005

Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells

Hiroki Kawamura, Hideo Yagita∥, Tetsuro Nisizawa, Nakako Izumi, Chikako Miyaji, Russell E. Vance, David H Raulet, Ko Okumura, Toru Abo

Article2025

Real-world outcomes of venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients related to acute myocardial infarction: a single-center experience

Jae Il Shin, Elise Kang, Seon Hwa Lee, Moonseong Heo, Yong‐Jae Lee, S J Lee, Soon Jun Hong, Jong Soo Kim, B K Kim, Young‐Guk Ko, Dong‐Ju Choi, Myeong‐Ki Hong, Yangsoo Jang, Cheol Min Ahn

Article2011

Clinical Patterns of Acute Poststreptococcal Glomerulonephritis: A Single Center's Experience

Rita Yu, Se-Jin Park, Jae Il Shin, Kee Hyuck Kim

Article2025

Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective

Jessica Elliott, Rachel Koldej, Amit Khot, David Ritchie